| Part one of this article, which appeared in the last edition of EBR (1), was concerned with the function and importance of intellectual property due diligence in the context of biotechnology and pharmaceutical technology transfer agreements. Having looked at this crucial aspect of the pre-contract process, this second part of the series focuses on the closely related topic of contractual warranties and considers some 'frequently asked questions'. |
